CJC-1295 research guide

CJC-1295 in Prosika — GHRH Analog Research Guide

CJC-1295 research guide for Prosika. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

CJC-1295 Near Prosika — What Researchers Need to Know

Unlike everyday supplements stocked in every health store, CJC-1295 reaches researchers through a dedicated online market that Prosika residents reach through online vendors. This online-only market structure is actually an advantage for quality — top vendors differentiate through analytical documentation in ways no local retailer can match. The key verification criteria for CJC-1295 are HPLC purity ≥98%, molecular identity verified through mass spectrometry, and a bacterial endotoxin panel — all documented in a batch-specific Certificate of Analysis. Use this guide to evaluate CJC-1295 vendors rigorously — the framework here are universal across all research contexts.

The Science Behind CJC-1295

The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Prosika researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.

CJC-1295 Purchasing Guide

Quality CJC-1295 sourcing begins with a simple filter: does this vendor publish batch-specific COAs proactively? Vendors who do are operating transparently. Mass spectrometry in the COA establishes that the main HPLC peak is actually CJC-1295 and not a structurally similar impurity — HPLC purity alone provides no identity confirmation. Warning signs in CJC-1295 vendor evaluation: prices far under typical market pricing, vague sourcing information, no community presence, and COAs that omit endotoxin testing. For Prosika researchers making a first CJC-1295 purchase: apply these quality criteria before ordering, order conservatively at first, and confirm the COA batch number matches your received product before use.

Order CJC-1295 — ships to Prosika
COA-verified · International tracking · Research grade
Order Now →

Handling CJC-1295 Correctly

All use of CJC-1295 in Prosika or anywhere must be research use only — this compound is not approved for clinical human use, and all handling should follow research laboratory protocols. Reconstitute CJC-1295 with bacteriostatic water at a concentration matched to your dosing requirements; a standard 5mg vial with 2mL bac water yields 2.5mg/mL — or 25mcg per insulin syringe unit. Quality CJC-1295 sourcing is inseparable from safety — bacterial endotoxin contamination, incorrect identity, and breakdown products are all safety issues that proper COA verification addresses. For any individual considering CJC-1295 outside a formal research context: speak with a healthcare professional — this compound is not a licensed human medication and its safety characterisation does not match that of regulated drugs.

Frequently Asked Questions

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →